Spruce Biosciences, Inc. · NASDAQ:SPRB
Orbimed Advisors LLC reported a 5.60% stake in Spruce Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Orbimed Advisors LLC reported a 5.60% stake in Spruce Biosciences, Inc., 162,000 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 162,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 5.60% | 162,000 |
| OrbiMed Genesis GP LLC | 5.60% | 162,000 |
| OrbiMed Capital LLC | 2.80% | 80,800 |
Source
Download original · View original at SEC
Related
- Spruce Biosciences, Inc.
- Orbimed Advisors LLC
- Spruce Biosciences, Inc. shareholders
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026